E1	Age:T1 Eq-Comparison:E2
E2	Eq-Comparison:T2 Value:T46 Operator:T47 Value2:T48
E3	Condition:T3 Name:T49 Stage:E4
E4	Eq-Comparison:T4 Value:T50 Operator:T51 Value:T52
E5	Condition:T5 Name:T53
E6	Condition:T6 Name:T55 Severity:T54
E7	Eq-Comparison:T7 Operator:T56 Value:T57 Per:T90
E8	Condition:T8 Name:T58
E10	Condition:T10 Acuteness:T9
E11	Condition:T11 Name:T60
E13	Condition:T13 Name:T61 Acuteness:T12
E14	Or:T14 Arg:E13 Arg2:E16
E15	Modifier:T15 Modifies:T62
E16	Condition:T16 Name:T62
E17	Condition:T17 Name:T63
E18	Or:T18 Arg:E17
E19	Eq-Comparison:T19 Temporal-Period:T64
E20	Condition:T20 Name:T65 Temporality:E19
E21	Modifier:T21 Modifies:T65
E23	Eq-Comparison:T23 Temporal-Period:T66
E24	Drug:T24 Name:T67 Temporality:E23
E25	Or:T25 Arg:E24 Arg2:E26
E26	Drug:T26 Name:T68
E27	Drug:T27 Name:T69 Temporality:E28
E28	Eq-Comparison:T28 Operator:T70 Value:T71 Temporal-Unit:T72
E29	Temporal-Connection:T29 Arg:E28 Arg2:E30
E30	Procedure:T30
E31	Observation:T31 Name:T74 Eq-Comparison:E32
E32	Eq-Comparison:T32 Operator:T75 Value:T76 Unit:T77 Per:T78
E33	Negation:T33 Negates:E31
E34	Condition:T34 Name:T79
E35	Or:T35 Arg:E47 Arg2:E36
E36	Modifier:T36 Modifies:T79
E37	Condition:T37 Name:T80
E38	Drug:T38 Name:T82
E40	Procedure:T40 Temporality:E41
E41	Eq-Comparison:T41 Operator:T83 Value:T84 Temporal-Unit:T85
E42	Or:T42 Arg:E40 Arg2:E44
E44	Drug:T44 Name:T86 Temporality:E45
E45	Eq-Comparison:T45 Operator:T87 Value:T88 Temporal-Unit:T89
E46	Modifier:T59 Modifies:T63
E22	Procedure:T22
E47	Modifier:T73 Modifies:T79
E39	Modifier:T39 Modifies:T86
T1	Age 65 68	Age
T2	Eq-Comparison 70 75	20-50
T3	Condition 100 116	Fitzpatrick skin
T4	Eq-Comparison 117 129	types III-IV
T5	Condition 177 206	platelet dysfunction syndrome
T6	Condition 217 233	thrombocytopenia
T7	Eq-Comparison 235 245	<50,000/ul
T8	Condition 252 275	hemodynamic instability
T9	Acuteness 301 308	chronic
T10	Condition 309 324	medical illness
T11	Condition 331 339	diabetes
T12	Acuteness 341 348	chronic
T13	Condition 349 359	infections
T14	Or 361 364	and
T15	Modifier 365 370	blood
T16	Condition 371 381	dyscrasias
T17	Condition 427 441	skin disorders
T18	Or 442 444	or
T19	Eq-Comparison 445 451	active
T20	Condition 452 468	herpes infection
T21	Modifier 476 480	site
T23	Eq-Comparison 518 520	on
T24	Drug 539 554	anti-coagulants
T25	Or 555 557	or
T26	Drug 558 595	non-steroidal anti-inflammatory drugs
T27	Drug 597 602	NSAID
T28	Eq-Comparison 604 619	within 48 hours
T29	Temporal-Connection 620 622	of
T30	Procedure 623 632	procedure
T31	Observation 644 655	Haemoglobin
T32	Eq-Comparison 661 670	< 10 g/dl
T33	Negation 681 689	excluded
T34	Condition 715 721	cancer
T35	Or 748 750	or
T36	Modifier 754 758	bone
T37	Condition 770 778	Pregnant
T38	Drug 812 827	corticosteroids
T40	Procedure 841 850	treatment
T41	Eq-Comparison 856 870	within 1 month
T42	Or 871 873	or
T44	Drug 890 905	corticosteroids
T45	Eq-Comparison 906 920	within 2 weeks
T46	Eq-Value 70 72	20
T47	Eq-Operator 72 73	-
T48	Eq-Value 73 75	50
T49	Condition-Name 100 116	Fitzpatrick skin
T50	Eq-Value 123 126	III
T51	Eq-Operator 126 127	-
T52	Eq-Value 127 129	IV
T53	Condition-Name 177 206	platelet dysfunction syndrome
T54	Severity 208 216	critical
T55	Condition-Name 217 233	thrombocytopenia
T56	Eq-Operator 235 236	<
T57	Eq-Value 236 242	50,000
T58	Condition-Name 252 275	hemodynamic instability
T60	Condition-Name 331 339	diabetes
T61	Condition-Name 349 359	infections
T62	Condition-Name 371 381	dyscrasias
T63	Condition-Name 427 441	skin disorders
T64	Eq-Temporal-Period 445 451	active
T65	Condition-Name 452 468	herpes infection
T66	Eq-Temporal-Period 518 520	on
T67	Drug-Name 539 554	anti-coagulants
T68	Drug-Name 558 595	non-steroidal anti-inflammatory drugs
T69	Drug-Name 597 602	NSAID
T70	Eq-Operator 604 610	within
T71	Eq-Value 611 613	48
T72	Eq-Temporal-Unit 614 619	hours
T74	Observation-Name 644 655	Haemoglobin
T75	Eq-Operator 661 662	<
T76	Eq-Value 663 665	10
T77	Eq-Unit 666 667	g
T78	Eq-Unit 668 670	dl
T79	Condition-Name 715 721	cancer
T80	Condition-Name 770 778	Pregnant
T81	Life-Stage-And-Gender 779 786	females
T82	Drug-Name 812 827	corticosteroids
T83	Eq-Operator 856 862	within
T84	Eq-Value 863 864	1
T85	Eq-Temporal-Unit 865 870	month
T86	Drug-Name 890 905	corticosteroids
T87	Eq-Operator 906 912	within
T88	Eq-Value 913 914	2
T89	Eq-Temporal-Unit 915 920	weeks
T90	Eq-Unit 243 245	ul
T59	Modifier 408 426	local inflammatory
T22	Procedure 488 497	procedure
T73	Modifier 734 747	hematopoietic
T39	Modifier 874 882	systemic
A1	Temporal-Connection-Type-Value E29 before
A2	Eq-Operator-Value T47 BETWEEN
A3	Eq-Operator-Value T51 BETWEEN
A4	Severity-Value T54 severe
A5	Eq-Operator-Value T56 LT
A6	Eq-Temporal-Period-Value T64 present
A7	Eq-Temporal-Period-Value T66 present
A8	Eq-Operator-Value T70 LTEQ
A9	Eq-Temporal-Unit-Value T72 hour
A10	Observation-Type-Value T74 lab
A11	Eq-Operator-Value T75 LT
A12	Life-Stage-And-Gender-Type T81 female
A13	Eq-Operator-Value T83 LTEQ
A14	Eq-Temporal-Unit-Value T85 month
A15	Eq-Operator-Value T87 LTEQ
A16	Eq-Temporal-Unit-Value T89 week
A17	Acuteness-Type-Value T9 chronic
A18	Acuteness-Type-Value T12 chronic
R1	Example-Of Arg1:E11 Arg2:E10
R2	Example-Of Arg1:E13 Arg2:E10
R3	Example-Of Arg1:E16 Arg2:E10
R4	Abbrev-Of Arg1:E27 Arg2:E26
R5	If-Then Arg1:E37 Arg2:T81
R6	Using Arg1:E40 Arg2:E38